| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.
|
Nat Genet
|
2007
|
22.96
|
|
2
|
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.
|
Nat Genet
|
2007
|
21.18
|
|
3
|
Multiple loci identified in a genome-wide association study of prostate cancer.
|
Nat Genet
|
2008
|
17.65
|
|
4
|
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).
|
Nat Genet
|
2009
|
8.39
|
|
5
|
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
|
Nat Genet
|
2009
|
7.30
|
|
6
|
The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk.
|
JAMA Pediatr
|
2013
|
6.18
|
|
7
|
Performance of common genetic variants in breast-cancer risk models.
|
N Engl J Med
|
2010
|
5.79
|
|
8
|
Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010.
|
JAMA
|
2012
|
4.71
|
|
9
|
Identification of a new prostate cancer susceptibility locus on chromosome 8q24.
|
Nat Genet
|
2009
|
3.76
|
|
10
|
Leisure time spent sitting in relation to total mortality in a prospective cohort of US adults.
|
Am J Epidemiol
|
2010
|
3.64
|
|
11
|
A common 8q24 variant in prostate and breast cancer from a large nested case-control study.
|
Cancer Res
|
2007
|
3.08
|
|
12
|
Genome-wide association study identifies new prostate cancer susceptibility loci.
|
Hum Mol Genet
|
2011
|
2.51
|
|
13
|
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.
|
Hum Mol Genet
|
2012
|
2.45
|
|
14
|
Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
2.45
|
|
15
|
Variation in KLK genes, prostate-specific antigen and risk of prostate cancer.
|
Nat Genet
|
2008
|
2.45
|
|
16
|
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study.
|
J Natl Cancer Inst
|
2012
|
2.21
|
|
17
|
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.
|
Cancer Res
|
2007
|
1.82
|
|
18
|
Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.
|
Proc Natl Acad Sci U S A
|
2009
|
1.81
|
|
19
|
Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies.
|
Genet Med
|
2013
|
1.55
|
|
20
|
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
|
PLoS One
|
2008
|
1.50
|
|
21
|
Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.44
|
|
22
|
Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research.
|
Genet Med
|
2012
|
1.39
|
|
23
|
Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort.
|
Breast Cancer Res
|
2006
|
1.37
|
|
24
|
Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.30
|
|
25
|
The role of body weight in the relationship between physical activity and endometrial cancer: results from a large cohort of US women.
|
Int J Cancer
|
2008
|
1.24
|
|
26
|
Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.23
|
|
27
|
Biobanking for research: a survey of patient population attitudes and understanding.
|
J Community Genet
|
2013
|
1.20
|
|
28
|
A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
|
Hum Mol Genet
|
2010
|
1.18
|
|
29
|
Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer.
|
Hum Mol Genet
|
2011
|
1.17
|
|
30
|
Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.
|
Hum Mol Genet
|
2010
|
1.16
|
|
31
|
Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.15
|
|
32
|
PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).
|
Carcinogenesis
|
2009
|
1.13
|
|
33
|
Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype.
|
Cancer
|
2009
|
1.11
|
|
34
|
Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.
|
Cancer Res
|
2010
|
1.06
|
|
35
|
A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
|
J Clin Endocrinol Metab
|
2010
|
1.04
|
|
36
|
No association between polymorphisms in LEP, LEPR, ADIPOQ, ADIPOR1, or ADIPOR2 and postmenopausal breast cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.03
|
|
37
|
Analysis of cohort studies with multivariate and partially observed disease classification data.
|
Biometrika
|
2010
|
1.01
|
|
38
|
Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3).
|
Hum Mol Genet
|
2009
|
1.01
|
|
39
|
KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.00
|
|
40
|
A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
|
Breast Cancer Res
|
2005
|
1.00
|
|
41
|
Risk factors for fatal breast cancer in African-American women and White women in a large US prospective cohort.
|
Am J Epidemiol
|
2005
|
1.00
|
|
42
|
Haplotypes of the estrogen receptor beta gene and breast cancer risk.
|
Int J Cancer
|
2008
|
0.99
|
|
43
|
A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
|
Breast Cancer Res
|
2006
|
0.97
|
|
44
|
CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.97
|
|
45
|
Perception of direct-to-consumer genetic testing and direct-to-consumer advertising of genetic tests among members of a large managed care organization.
|
J Genet Couns
|
2012
|
0.94
|
|
46
|
Large-scale fine mapping of the HNF1B locus and prostate cancer risk.
|
Hum Mol Genet
|
2011
|
0.94
|
|
47
|
Weight loss and postmenopausal breast cancer in a prospective cohort of overweight and obese US women.
|
Cancer Causes Control
|
2011
|
0.90
|
|
48
|
Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels.
|
Hum Genet
|
2011
|
0.90
|
|
49
|
Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen.
|
Int J Cancer
|
2010
|
0.89
|
|
50
|
Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database.
|
BMC Cancer
|
2012
|
0.86
|
|
51
|
Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women.
|
J Clin Endocrinol Metab
|
2014
|
0.85
|
|
52
|
Utilization of HER2 genetic testing in a multi-institutional observational study.
|
Am J Manag Care
|
2012
|
0.82
|
|
53
|
CYP17 genotype predicts serum hormone levels among pre-menopausal women.
|
Hum Reprod
|
2005
|
0.82
|
|
54
|
Cryopreservation of whole blood samples collected in the field for a large epidemiologic study.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.81
|
|
55
|
Family history of various cancers and pancreatic cancer mortality in a large cohort.
|
Cancer Causes Control
|
2009
|
0.81
|
|
56
|
Concerning the CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.
|
Mutagenesis
|
2002
|
0.79
|
|
57
|
Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
|
BMC Cancer
|
2009
|
0.78
|
|
58
|
Jewish ethnicity and prostate cancer mortality in two large US cohorts.
|
Cancer Causes Control
|
2002
|
0.77
|
|
59
|
Reply: To PMID 23490543.
|
J Am Coll Surg
|
2013
|
0.75
|
|
60
|
Fine mapping of 14q24.1 breast cancer susceptibility locus.
|
Hum Genet
|
2011
|
0.75
|
|
61
|
Bariatric Surgery and the Risk of Cancer in a Large Multisite Cohort.
|
Ann Surg
|
2017
|
0.75
|
|
62
|
Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women.
|
Am J Epidemiol
|
2017
|
0.75
|